Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
76,086
+5,464
+8% +$84.7K 0.13% 247
2026
Q1
$954K Buy
+70,622
New +$988K 0.12% 251
2025
Q4
Sell
-37,256
Closed -$369K 946
2025
Q3
$369K Buy
+37,256
New +$363K 0.14% 263
2024
Q3
Sell
-15,470
Closed -$164K 615
2024
Q2
$164K Sell
15,470
-11,230
-42% -$124K 0.04% 413
2024
Q1
$319K Buy
+26,700
New +$322K 0.08% 416
2023
Q2
Sell
-16,853
Closed -$162K 587
2023
Q1
$162K Buy
+16,853
New +$187K 0.06% 420

Other funds holding VTRS

AXQ Capital's VTRS Position: Q2 2026 in Review

AXQ Capital increased its Viatris (VTRS) stake by 7.7% in Q2 2026, buying an estimated $84.7K and bringing the position to 76,086 shares worth $1.21M. The position accounts for 0.13% of the portfolio, ranked #247.

AXQ Capital first reported a position in VTRS in Q1 2023 and has held it in 6 quarters since. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • AXQ Capital held 76,086 shares of Viatris worth $1.21M as of Q2 2026.
  • AXQ Capital bought 5,464 Viatris shares in Q2 2026, an estimated $84.7K.
  • Viatris made up 0.13% of AXQ Capital's portfolio in Q2 2026, its #247 holding.
  • AXQ Capital first reported a position in Viatris in Q1 2023 and has held it in 6 quarters since.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.